• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GM4951 相关免疫 GTPase 的缺失导致非酒精性脂肪肝而不伴肥胖。

Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity.

机构信息

Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

Division of Endocrinology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

出版信息

Nat Commun. 2022 Jul 16;13(1):4136. doi: 10.1038/s41467-022-31812-4.

DOI:10.1038/s41467-022-31812-4
PMID:35842425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9288484/
Abstract

Obesity and diabetes are well known risk factors for nonalcoholic fatty liver disease (NAFLD), but the genetic factors contributing to the development of NAFLD remain poorly understood. Here we describe two semi-dominant allelic missense mutations (Oily and Carboniferous) of Predicted gene 4951 (Gm4951) identified from a forward genetic screen in mice. GM4951 deficient mice developed NAFLD on high fat diet (HFD) with no changes in body weight or glucose metabolism. Moreover, HFD caused a reduction in the level of Gm4951, which in turn promoted the development of NAFLD. Predominantly expressed in hepatocytes, GM4951 was verified as an interferon inducible GTPase. The NAFLD in Gm4951 knockout mice was associated with decreased lipid oxidation in the liver and no defect in hepatic lipid secretion. After lipid loading, hepatocyte GM4951 translocated to lipid droplets (LDs), bringing with it hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), which in the absence of GM4951 did not undergo this translocation. We identified a rare non-obese mouse model of NAFLD caused by GM4951 deficiency and define a critical role for GTPase-mediated translocation in hepatic lipid metabolism.

摘要

肥胖和糖尿病是众所周知的非酒精性脂肪性肝病(NAFLD)的危险因素,但导致 NAFLD 发展的遗传因素仍知之甚少。在这里,我们描述了从小鼠正向遗传筛选中鉴定出的预测基因 4951(Gm4951)的两个半显性等位基因突变(油性和石炭纪)。GM4951 缺陷型小鼠在高脂肪饮食(HFD)下发生 NAFLD,体重和葡萄糖代谢没有变化。此外,HFD 导致 Gm4951 水平降低,进而促进 NAFLD 的发展。GM4951 主要在肝细胞中表达,被验证为干扰素诱导的 GTPase。Gm4951 敲除小鼠的 NAFLD 与肝脏脂质氧化减少有关,肝脂质分泌无缺陷。在脂质负荷后,肝细胞 GM4951 易位到脂质滴(LDs),并随之带来羟甾体 17β-脱氢酶 13(HSD17B13),在没有 GM4951 的情况下,HSD17B13 不会发生这种易位。我们发现了一种由 GM4951 缺乏引起的罕见非肥胖型 NAFLD 小鼠模型,并确定了 GTPase 介导的易位在肝脂质代谢中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/1b4788135f84/41467_2022_31812_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/177bb42b460c/41467_2022_31812_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/e73cae04d5b9/41467_2022_31812_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/7987f470615a/41467_2022_31812_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/d28fac876bdc/41467_2022_31812_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/492848e13fc1/41467_2022_31812_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/6947acb97aef/41467_2022_31812_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/ab389e8f3d40/41467_2022_31812_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/1b4788135f84/41467_2022_31812_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/177bb42b460c/41467_2022_31812_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/e73cae04d5b9/41467_2022_31812_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/7987f470615a/41467_2022_31812_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/d28fac876bdc/41467_2022_31812_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/492848e13fc1/41467_2022_31812_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/6947acb97aef/41467_2022_31812_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/ab389e8f3d40/41467_2022_31812_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a0/9288484/1b4788135f84/41467_2022_31812_Fig8_HTML.jpg

相似文献

1
Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity.GM4951 相关免疫 GTPase 的缺失导致非酒精性脂肪肝而不伴肥胖。
Nat Commun. 2022 Jul 16;13(1):4136. doi: 10.1038/s41467-022-31812-4.
2
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.樟芝及其复合成分去氢表雄酮酸通过上调 ALDH2 活性来减轻非酒精性脂肪肝疾病。
J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16.
3
Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation.肝细胞分泌的 FAM3D 通过激活 FPR1-hnRNP U-GR-SCAD 通路增强脂质氧化来改善肝脂肪变性。
Metabolism. 2023 Sep;146:155661. doi: 10.1016/j.metabol.2023.155661. Epub 2023 Jul 16.
4
APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.载脂蛋白C3蛋白并非小鼠脂肪诱导的非酒精性脂肪性肝病的诱发因素。
J Biol Chem. 2017 Mar 3;292(9):3692-3705. doi: 10.1074/jbc.M116.765917. Epub 2017 Jan 23.
5
1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.1,2,3,4,6-五没食子酰基-β-D-葡萄糖可改善高脂饮食诱导的非酒精性脂肪肝病,并维持参与脂类动态平衡的基因在小鼠体内的表达。
Biomed Pharmacother. 2020 Sep;129:110348. doi: 10.1016/j.biopha.2020.110348. Epub 2020 Jun 15.
6
Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.维生素 D 受体靶向肝细胞核因子 4α 并介导维生素 D 在非酒精性脂肪性肝病中的保护作用。
J Biol Chem. 2020 Mar 20;295(12):3891-3905. doi: 10.1074/jbc.RA119.011487. Epub 2020 Feb 12.
7
Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.免疫相关 GTPase 诱导脂噬以防止肝脏脂质过度积累。
J Hepatol. 2020 Oct;73(4):771-782. doi: 10.1016/j.jhep.2020.04.031. Epub 2020 May 4.
8
In Vivo Two-Photon Imaging Analysis of Dynamic Degradation of Hepatic Lipid Droplets in MS-275-Treated Mouse Liver.体内双光子成像分析 MS-275 处理的小鼠肝中肝脂滴的动态降解。
Int J Mol Sci. 2022 Sep 1;23(17):9978. doi: 10.3390/ijms23179978.
9
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.血小板反应蛋白 1 可改善饮食诱导的胰岛素抵抗小鼠的肝脂肪变性,并且与人类的肝脂肪含量相关。
EBioMedicine. 2020 Jul;57:102849. doi: 10.1016/j.ebiom.2020.102849. Epub 2020 Jun 21.
10
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.漆黄素通过调节高脂肪饮食诱导的肥胖小鼠中的Sirt1/AMPK和脂肪酸β-氧化信号通路来预防肝脂肪变性。
Cell Physiol Biochem. 2018;49(5):1870-1884. doi: 10.1159/000493650. Epub 2018 Sep 20.

引用本文的文献

1
A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency.一个低表达的Mpi突变开启了一种用于研究整体N-糖基化缺陷的体内工具。
JCI Insight. 2025 Jul 22;10(14). doi: 10.1172/jci.insight.180752.
2
KBTBD2 controls bone development by regulating IGF-1 signaling during osteoblast differentiation.KBTBD2通过在成骨细胞分化过程中调节IGF-1信号通路来控制骨骼发育。
Cell Death Differ. 2024 Nov 19. doi: 10.1038/s41418-024-01416-0.
3
Transcriptomics-based anti-tuberculous mechanism of traditional Chinese polyherbal preparation NiuBeiXiaoHe intermediates.

本文引用的文献

1
Pfam: The protein families database in 2021.Pfam:2021 年的蛋白质家族数据库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419. doi: 10.1093/nar/gkaa913.
2
17-Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury.17-β 羟甾体脱氢酶 13 缺乏症不能保护小鼠免受致肥胖饮食的损伤。
Hepatology. 2021 May;73(5):1701-1716. doi: 10.1002/hep.31517. Epub 2021 Mar 16.
3
Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.免疫相关 GTPase 诱导脂噬以防止肝脏脂质过度积累。
基于转录组学的中药复方制剂牛贝消核中间体抗结核机制
Front Pharmacol. 2024 Sep 19;15:1415951. doi: 10.3389/fphar.2024.1415951. eCollection 2024.
4
Transcriptomic Signatures of the Foetal Liver and Late Prenatal Development in Vitrified Rabbit Embryos.玻璃化兔胚胎中胎儿肝脏和产前晚期发育的转录组特征
Vet Sci. 2024 Aug 1;11(8):347. doi: 10.3390/vetsci11080347.
5
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.探讨遗传变异在非酒精性脂肪性肝病中的作用:对疾病发病机制和精准医学方法的启示。
Eur J Med Res. 2024 Mar 20;29(1):190. doi: 10.1186/s40001-024-01708-8.
6
Triglycerides Mediate the Influence of Body Mass Index on Non-Alcoholic Fatty Liver Disease in a Non-Obese Chinese Population with Normal Low-Density Lipoprotein Cholesterol Levels.甘油三酯介导了体重指数对正常低密度脂蛋白胆固醇水平的非肥胖中国人群中非酒精性脂肪性肝病的影响。
Obes Facts. 2024;17(2):191-200. doi: 10.1159/000536447. Epub 2024 Jan 24.
7
Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study.非肥胖成年人非酒精性脂肪肝与左心室舒张功能障碍的相关性:一项横断面研究。
BMC Gastroenterol. 2023 Mar 27;23(1):90. doi: 10.1186/s12876-023-02708-4.
8
Metabolic effects of CCL5 deficiency in lean and obese mice.CCL5 缺乏对瘦型和肥胖型小鼠代谢的影响。
Front Immunol. 2023 Jan 13;13:1059687. doi: 10.3389/fimmu.2022.1059687. eCollection 2022.
J Hepatol. 2020 Oct;73(4):771-782. doi: 10.1016/j.jhep.2020.04.031. Epub 2020 May 4.
4
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.纤维化分期与非酒精性脂肪性肝病患者结局的相关性:系统评价和荟萃分析。
Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4.
5
Considering the Links Between Nonalcoholic Fatty Liver Disease and Insulin Resistance: Revisiting the Role of Protein Kinase C ε.探讨非酒精性脂肪性肝病与胰岛素抵抗之间的联系:重新审视蛋白激酶Cε的作用
Hepatology. 2019 Dec;70(6):2217-2220. doi: 10.1002/hep.30829. Epub 2019 Aug 23.
6
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中胰岛素抵抗的调节。
Hepatology. 2019 Aug;70(2):711-724. doi: 10.1002/hep.30429. Epub 2019 Jul 19.
7
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.17-β 羟甾类脱氢酶 13 是一种与非酒精性脂肪性肝病组织学特征相关的肝视黄醇脱氢酶。
Hepatology. 2019 Apr;69(4):1504-1519. doi: 10.1002/hep.30350. Epub 2019 Mar 5.
8
HSD17B13 and Chronic Liver Disease in Blacks and Hispanics.HSD17B13与黑人和西班牙裔人群的慢性肝病
N Engl J Med. 2018 Nov 8;379(19):1876-1877. doi: 10.1056/NEJMc1804027.
9
The New Face of the Lipid Droplet: Lipid Droplet Proteins.脂质滴的新面貌:脂质滴蛋白。
Proteomics. 2019 May;19(10):e1700223. doi: 10.1002/pmic.201700223. Epub 2018 Oct 8.
10
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.一种截短蛋白的HSD17B13变体与慢性肝病的防护
N Engl J Med. 2018 Mar 22;378(12):1096-1106. doi: 10.1056/NEJMoa1712191.